[
  {
    "ts": "2025-12-30T04:59:44+00:00",
    "headline": "Here’s What Analysts Think About Pfizer Inc. (PFE)",
    "summary": "Pfizer Inc. (NYSE:PFE) is one of the best affordable healthcare stocks to buy now. Scotiabank analyst Louise Chen reiterated a Buy rating on Pfizer Inc. (NYSE:PFE) on December 17 and set a price target of $30.00. The same day, Bernstein analyst Courtney Breen reiterated a Hold rating on the stock, keeping the associated price target the […]",
    "url": "https://finance.yahoo.com/news/analysts-think-pfizer-inc-pfe-045944487.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "1e2309eb-77bd-35e7-ba2e-00e8651e5f50",
      "content": {
        "id": "1e2309eb-77bd-35e7-ba2e-00e8651e5f50",
        "contentType": "STORY",
        "title": "Here’s What Analysts Think About Pfizer Inc. (PFE)",
        "description": "",
        "summary": "Pfizer Inc. (NYSE:PFE) is one of the best affordable healthcare stocks to buy now. Scotiabank analyst Louise Chen reiterated a Buy rating on Pfizer Inc. (NYSE:PFE) on December 17 and set a price target of $30.00. The same day, Bernstein analyst Courtney Breen reiterated a Hold rating on the stock, keeping the associated price target the […]",
        "pubDate": "2025-12-30T04:59:44Z",
        "displayTime": "2025-12-30T04:59:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Pfizer’s (PFE) Pipeline and Dividend Yield Make it a Compelling Income Stock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/UKiv8LHLxutAA7dDIzr_pw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/1v0rnd.QZj0de1gLzaNuAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/aef4b35e5ea946bf7f4ed347e5c4f487.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/analysts-think-pfizer-inc-pfe-045944487.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/analysts-think-pfizer-inc-pfe-045944487.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]